Endpoints and Trial Designs to Advance Development in Kidney Transplantation
Thu, Nov 09
|https://www.fda.gov/drugs/news-events-human
AAKP ACTION ALERT: NOVEMBER 9 *VIRTUAL FDA MEETING* TRANSPLANT DRUGS * REGISTER PLEASE!
Time & Location
Nov 09, 2023, 8:00 AM – 4:30 PM EST
https://www.fda.gov/drugs/news-events-human
About the event
Dear AAKP Ambassadors, Friends, and Allies:
Over the past year, AAKP has highlighted the unmet needs of transplant patients and transplant professionals and the long-overdue need for innovations to transcend status quo immunosuppressive drugs. These drugs were developed over 20 or 40 years ago based on an endpoint of 1-year graft survival, with no substantive consideration of drug side effects like nephrotoxicity or long-term transplant patient outcomes.
On November 9th from 8:00 a.m. - 4:30 p.m. ET, the U.S. Food and Drug Administration (FDA) is hosting a Public Workshop titled “Endpoints and Trial Designs to Advance Development in Kidney Transplantation.” This is a hybrid event, so we strongly encourage all Ambassadors and Allies to register to join virtually. You can learn more about the workshop, view the agenda, and register by clicking here.
We need you to attend, listen, and ask the FDA panelists questions during the discussion period on what the agency…